Ab Index-Nr. 607-219-00-6

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
607-219-00-6bis(2-ethylhexyl) dithiodiacetate404-510-862268-47-7Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
   
607-221-00-76-docosyloxy-1-hydroxy-
4-(1-(4-hydroxy-3-methyl-
phenanthren-1-yl)-3-oxo-2-
oxaphenalen-1-yl)naphtha-
lene-2-carboxylic acid
404-550-6Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
607-222-00-26-(2,3-dimethylmaleimi-
do)hexyl methacrylate
404-870-663740-41-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-223-00-8transfluthrin (ISO);
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-
dimethylcyclopropane-
carboxylate
405-060-5118712-89-3Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
   
607-224-00-3methyl 2-(3-nitrobenzylide-
ne)acetoacetate
405-270-739562-17-9Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
607-225-00-93-azidosulfonylbenzoic acid405-310-315980-11-7Self-React. C
(*)(*)(*)(*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
H241
H373 (*)(*)
H318
H317
GHS02
GHS08
GHS05
GHS07
Dgr
H241
H373 (*)(*)
H318
H317
   
607-226-00-4reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxy-
late and 2-methacryloy-
loxyethyl hydrogen cyclohe-
xane-1,2-dicarboxylate
405-360-6Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H315
H318
H317
H412
GHS05
GHS07
Dgr
H315
H318
H317
H412
   
607-227-00-Xpotassium 2-amino-2-
methylpropionate
octahydrate
405-560-3120447-91-8Acute Tox. 4 (*)
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314
   
607-228-00-5bis(2-methoxyethyl) phthalate204-212-6117-82-8Repr. 1BH360DfGHS08
Dgr
H360Df   
607-229-00-0diethylcarbamoyl chloride201-798-588-10-8Carc. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H351
H332
H302
H319
H335
H315
GHS08
GHS07
Wng
H351
H332
H302
H319
H335
H315
   
607-230-00-62-ethylhexanoic acid205-743-6149-57-5Repr. 2H361d
(*)(*)(*)
GHS08
Wng
H361d
(*)(*)(*)
   
607-231-00-1clopyralid (ISO);
3,6-dichloropyridine-2-
carboxylic acid
216-935-41702-17-6Eye Dam. 1H318GHS05
Dgr
H318   
607-232-00-7pyridate (ISO);
O-(6-chloro-3-phenylpyridazin-
4-yl) S-octyl thiocarbonate
259-686-755512-33-9Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
   
607-233-00-2hexyl acrylate219-698-52499-95-8Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H335
H315
H317
H411
GHS07
GHS09
Wng
H319
H335
H315
H317
H411
   
607-234-00-8flurenol (ISO);
9-hydroxy-9H-fluorene-9-
carboxylic acid
207-397-1467-69-6Aquatic Chronic 2H411GHS09H411   
607-235-00-3mecrilate;
methyl 2-cyanoacrylate
205-275-2137-05-3Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
 STOT SE 3;
H335: C ≥ 10 %
 
607-236-00-9ethyl 2-cyanoacrylate230-391-57085-85-0Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
 STOT SE 3;
H335: C ≥ 10 %
 
607-237-00-4benzyl 2-chloro-4-(trifluoro-
methyl)thiazole-5-carboxylate;
flurazole
276-942-372850-64-7Aquatic Chronic 2H411GHS09H411   
607-238-00-Xtau-fluvalinate (ISO);
cyano-(3-phenoxy-
phenyl)methyl N-[2-chloro-4-(trifluoro-
methyl)phenyl]-D-valinate
102851-06-9Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410
   
607-239-00-5fenpropathrin (ISO);
α-cyano-3-phenoxy-
benzyl 2,2,3,3-tetrame-
thylcyclopropanecarboxylate
254-485-039515-41-8Acute Tox. 2 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
Eye Dam. 1
H330
H301
H312
H400
H410
H318
GHS06
GHS09
Dgr
GHS08
H330
H301
H312
H410
H318
  C
607-240-00-0cis-1,2,3,6-tetrahydro-4-
methylphthalic anhydride; [1]
1,2,3,6-tetrahydro-4-methyl-
phthalic anhydride; [2]
1,2,3,6-tetrahydro-3-methyl-
phthalic anhydride; [3]
tetrahydromethylphthalic anhydride; [4]
1,2,3,6-tetrahydromethyl-
phthalic anhydride; [5]
tetrahydro-4-methylphthalic anhydride; [6]
2,3,5,6-tetrahydro-2-methyl-
phthalic anhydride [7]
216-906-6 [1]
222-323-8 [2]
226-247-6 [3]
234-290-7 [4]
247-830-1 [5]
251-823-9 [6]
255-853-3 [7]
1694-82-2 [1]
3425-89-6 [2]
5333-84-6 [3]
11070-44-3 [4]
26590-20-5 [5]
34090-76-1 [6]
42498-58-8 [7]
Resp. Sens. 1
Skin Sens. 1
H334
H317
GHS05
Dgr
H334
H317
   
607-241-00-6hexahydro-4-methylphthalic anhydride; [1]
hexahydromethylphthalic anhydride; [2]
hexahydro-1-methylphthalic anhydride; [3]
hexahydro-3-methylphthalic anhydride [4]
243-072-0 [1]
247-094-1 [2]
256-356-4 [3]
260-566-1 [4]
19438-60-9 [1]
25550-51-0 [2]
48122-14-1 [3]
57110-29-9 [4]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317
  C
607-242-00-1tetrachlorophthalic anhydride204-171-4117-08-8Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H334
H317
H400
H410
GHS08
GHS05
GHS09
Dgr
H318
H334
H317
H410
   
607-243-00-7sodium 3,6-dichloro-o-anisate; [1]
3,6-dichloro-o-anisic acid, compound with
2,2'-iminodiethanol (1:1); [2]
3,6-dichloro-o-anisic acid, compound with
2-aminoethanol (1:1) [3]
217-846-3 [1]
246-590-5 [2]
258-527-9 [3]
1982-69-0 [1]
25059-78-3 [2]
53404-28-7 [3]
Aquatic Chronic 3H412H412   
607-244-00-2isooctyl acrylate249-707-829590-42-9Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410
 STOT SE 3;
H335: C ≥ 10 %
 
607-245-00-8tert-butyl acrylate216-768-71663-39-4Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H225
H332
H312
H302
H335
H315
H317
H411
GHS02
GHS07
GHS09
Dgr
H225
H332
H312
H302
H335
H315
H317
H411
  D
607-246-00-3allyl methacrylate;
2-methyl-2-propenoic acid 2-propenyl ester
202-473-096-05-9Flam. Liq. 3
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
H226
H331
H312
H302
H400
GHS02
GHS06
GHS09
Dgr
H226
H331
H312
H302
H400
   
607-247-00-9dodecyl methacrylate205-570-6142-90-5Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410
 STOT SE 3;
H335: C ≥ 10 %
 
607-248-00-4naptalam-sodium (ISO);
sodium N-naphth-1-ylphthalamate
205-073-4132-67-2Acute Tox. 4 (*)H302GHS07
Wng
H302   
607-249-00-X(1-methyl-1,2-ethane-
diyl)bis[oxy(methyl-
2,1-ethanediyl)] diacrylate
256-032-242978-66-5Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H335
H315
H317
H411
GHS07
GHS09
Wng
H319
H335
H315
H317
H411
 STOT SE 3;
H335: C ≥ 10 %
 
607-250-00-54H-3,1-benzoxazine-2,4(1H)-
dione
204-255-0118-48-9Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
   
607-251-00-02-methoxypropyl acetate274-724-270657-70-4Flam. Liq. 3
Repr. 1B
STOT SE 3
H226
H360D
(*)(*)(*)
H335
GHS02
GHS08
GHS07
Dgr
H226
H360D
(*)(*)(*)
H335
   
607-252-00-6lambda-cyhalothrin (ISO);
reaction mass of (S)-α-cyano-3-
phenoxybenzyl(Z)-(1R)-cis-
3-(2-chloro-3,3,3-trifluoropro-
penyl)-2,2-dimethylcyclopro-
panecarboxylate and (R)-αcyano-3-phenoxy-
benzyl (Z)-(1S)-cis-3-(2-chloro-
3,3,3-trifluoropropenyl)-2,2-
dimethylcyclopropanecar-
boxylate (1:1)
415-130-791465-08-6Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H312
H400
H410
GHS06
GHS09
Dgr
H330
H301
H312
H410
 M = 10000 
607-253-00-1cyfluthrin (ISO);
α-cyano-4-fluoro-3-
phenoxybenzyl-3-
(2,2-dichlorovinyl)-2,2-
dimethylcyclopropanecar-
boxylate
269-855-768359-37-5Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H331
H400
H410
GHS06
GHS09
Dgr
H300
H331
H410
 M = 1000 
607-254-00-7α-cyano-4-fluoro-3-
phenoxybenzyl-3-(2,2-
dichlorovinyl)-2,2-dimethyl-
cyclopropanecarboxylate;
beta-cyfluthrin
269-855-768359-37-5Acute Tox. 2 (*)
Acute Tox. 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H400
H410
GHS06
GHS09
Dgr
H330
H300
H410
   
607-255-00-2fluroxypyr (ISO);
4-amino-3,5-dichloro-6-
fluoro-2-pyridylo-
xyacetic acid
69377-81-7Aquatic Chronic 3H412H412   
607-256-00-8azoxystrobin (ISO);
methyl (E)-2-{2-[6-(2-cya-
nophenoxy)pyrimidin-4-
yloxy]phenyl}-3-methoxy-
acrylate
131860-33-8Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H400
H410
GHS06
GHS09
Dgr
H331
H410
   
607-257-00-3isopropyl propionate211-300-8637-78-5Flam. Liq. 2H225GHS02
Dgr
H225   
607-258-00-9dodecyl 3-(2-(3-benzyl-4-
ethoxy-2,5-dioxoimidazoli-
din-1-yl)-3-(4-methoxyben-
zoyl)acetamido)-4-chloro-
benzoate
403-990-670950-45-7Aquatic Chronic 4H413H413   
607-259-00-4methyl 2R,3S-(-)-3-(4-
methoxyphenyl)oxira-
necarboxylate
404-130-2105560-93-8Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
607-260-00-Xethyl 2-(3-nitrobenzyli-
dene)acetoacetate
404-490-039562-16-8Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
607-261-00-5iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxy-
phenyl)methylthioacetate
404-800-4118832-72-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-262-00-07-chloro-1-cyclopropyl-6-fluoro-
1,4-dihydro-4-oxoquinoline-
3-carboxylic acid
405-050-086393-33-1Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
607-263-00-6potassium iron(III) 1,3-propanediamine-N,
N,N',N'-tetraacetate hemihydrate
405-680-6Self-heat. 2
(*)(*)(*)(*)
Aquatic Chronic 2
H252
H411
GHS02
GHS09
Wng
H252
H411
   
607-264-00-12-chloro-4-(methylsulfon-
yl)benzoic acid
406-520-853250-83-2Eye Dam. 1H318GHS05
Dgr
H318   
607-265-00-7ethyl-2-chloro-2,2-diphenyl-
acetate
406-580-552460-86-3Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
   
607-266-00-2reaction mass of: hydroxyaluminium bis[2-
hydroxy-3,5-di-tert-butyl-
benzoate];
3,5-di-tert-butyl-salicylic acid
406-890-0130296-87-6Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
607-267-00-8tert-butyl (5S,6R,7R)-3-bromomethyl-
5,8-dioxo-7-(2-(2-phenylace-
tamido)-5-thia-1-azabicy-
clo[4.2.0] oct-2-ene-2-carboxylate
407-620-433610-13-8Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H334
H317
H412
GHS08
Dgr
H334
H317
H412
   
607-268-00-32-methylpropyl (R)-2-hydroxypropanoate407-770-061597-96-4Eye Irrit. 2H319GHS07
Wng
H319   
607-269-00-9(R)-2-(4-hydroxyphenoxy)pro-
panoic acid
407-960-394050-90-5Eye Dam. 1H318GHS05
Dgr
H318   
607-270-00-43,9-bis(2-(3-(3-tert-butyl-4-
hydroxy-5-methylphenyl)pro-
pionyloxy-1,1-dimethyle-
thyl)-2,4,8,10- tetra-
oxaspiro[5.5]undecane
410-730-590498-90-1Acute Tox. 4 (*)H312GHS07
Wng
H312   
607-271-00-X2-isopropyl-5-methylcyclo-
hexyloxycarbony-
loxy-2-hydroxypropane
417-420-9156324-82-2Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
   
607-272-00-5fluroxypyr-meptyl (ISO);
methylheptyl, O-(4-amino-3,5-dichloro-6-
fluoro-2-pyridyloxy) acetate; [1]
fluroxypyr-butometyl (ISO);
2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-
fluoro-2-pyridyloxy) acetate [2]
279-752-9 [1]
[2]
81406-37-3 [1]
154486-27-8 [2]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-273-00-0ammonium 7-(2,6-dimethyl-8-(2,2-dime-
thylbutyryloxy)-1,2,6,7,8,8a-
hexahydro-1-naphthyl)-3,5-
dihydroxyheptanoate
404-520-2Aquatic Chronic 3H412H412   
607-274-00-62-(N-benzyl-N-methylami-
no)ethyl 3-amino-
2-butenoate
405-350-154527-73-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-275-00-1sodium benzoyloxy-
benzene-4-sulfonate
405-450-566531-87-1Skin Sens. 1H317GHS07
Wng
H317   
607-276-00-7bis[(1-methylimidazol)-(2-ethyl-
hexanoate)],
zinc complex
405-635-0Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
   
607-277-00-2reaction mass of: 2-(hexylthio)ethylamine
hydrochloride;
sodium propionate
405-720-2Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
   
607-278-00-8reaction mass of isomers of: sodium phenethylnaphthalene-
sulfonate;
sodium naphthylethylbenzene-
sulfonate
405-760-0Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
607-279-00-3reaction mass of n-octadecylaminodiethyl
bis(hydrogen maleate);
n-octadecylaminodiethyl hydrogen maleate
hydrogenphthalate
405-960-8Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-280-00-9sodium 4-chloro-1-hydroxy-
butane-1-sulfonate
406-190-554322-20-2Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317
   
607-281-00-4reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-
yl)-5-(1,1-dimethylethyl)-4-
hydroxyphenyl]propionates
407-000-3127519-17-9Aquatic Chronic 2H411GHS09H411   
607-282-00-X2-acetoxymethyl-4-benzyloxy-
but-1-yl acetate
407-140-5131266-10-9Aquatic Chronic 3H412H412   
607-283-00-5E-ethyl-4-oxo-4-phenylcrotonate408-040-415121-89-8Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H315
H318
H317
H410
   
607-284-00-0reaction mass of: sodium 3,3'-(1,4-phenylenebis(car-
bonylimino-3,1-propanediyli-
mino))bis(10-amino-6,13-di-
chloro-4,11-triphenodioxazine-
disulfonate);
lithium 3,3'-(1,4-phenylenebis-
(carbonylimino-3,1-propanediyl-
imino))bis(10-amino-6,13-di-
chloro)-4,11-triphenodioxazi-
nedisulfonate (9:1)
410-040-4136213-76-8Aquatic Chronic 2H411GHS09H411   
607-285-00-6reaction mass of: 7-(((3-aminophenyl)sulfo-
nyl)amino)-naphthalene-1,3-
disulfonic acid;
sodium 7-(((3-aminophe-
nyl)sulfonyl)amino)-naphtha-
lene-1,3-disulfonate;
potassium 7-(((3-amino-
phenyl)sulfonyl)amino)-
naphthalene-1,3-disulfonate
410-065-0Skin Sens. 1H317GHS07
Wng
    
607-286-00-1reaction mass of: sodium/potassium 7-[[[3-
[[4-((2-hydroxy-naph-
thyl)azo)phenyl]azo]phenyl]sul-
fonyl]amino]-naphthalene-1,3-
disulfonate
410-070-8141880-36-6Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-287-00-7O'-methyl O-(1-methyl-2-me-
thacryloyloxyethyl)-1,2,3,6-
tetrahydrophthalate
410-140-8Aquatic Chronic 3H412H412   
607-288-00-2tetrasodium (c-(3-(1-(3-(e-6-di-
chloro-5-cyanopyrimidin-f-
yl(methyl)amino)propyl)-1,6-
dihydro-2-hydroxy-4-methyl-6-
oxo-3-pyridylazo)-4-sulfonato-
phenylsulfamoyl)phtha-
locyanine-a,b,d-trisulfo-
nato(6-))nickelato II,
where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively
410-160-7148732-74-5Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412
   
607-289-00-83-(3-(4-(2,4-bis(1,1-dimethyl-
propyl)phenoxy)butylamino-
carbonyl-4-hydroxy-1-
naphthalenyl)thio)propanoic acid
410-370-9105488-33-3Aquatic Chronic 4H413H413   
607-290-00-3reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-
allyloxy-2-hydroxypropoxy-
carbonyl)ethane-1-sulfonate;
ammonium 2-C14-C18-alkyloxycar­bonyl-1-
(3-allyloxy-2-hydroxy­propoxycarbonyl)ethane-1-sulfonate
410-540-2Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
   
607-291-00-9dodecyl-ω-(C5/C6-cyclo-
alkyl)alkyl carboxylate
410-630-1104051-92-5Aquatic Chronic 4H413H413   
607-292-00-4reaction mass of: [1-(methoxymethyl)-2-
(C12-alkoxy)-ethoxy]acetic acid;
[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]
acetic acid
410-640-6Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
   
607-293-00-Xreaction mass of: N-amino­ethylpipera­zonium mono-2,4,6-trimethyl­nonyldi­phenyl
ether di-sulfonate;
N-aminoethylpiperazonium di-2,4,6-trimethylnonyl­diphenyl ether di-sulfonate
410-650-0Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
   
607-294-00-5sodium 2-benzoyloxy-1-hydroxy­ethane-sulfonate410-680-4Skin Sens. 1H317GHS07
Wng
H317   
607-295-00-0reaction mass of: tetrasodium phosphonoe-
thane-1,2-dicarboxylate;
hexasodium phosphonobutane-1,2,3,4-tet-
racarboxylate
410-800-5Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-296-00-6reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid410-830-9Aquatic Chronic 4H413H413   
607-297-00-1(E–E)-3,3'-(1,4-phenylenedimethylidene)bis
(2-oxobornane-10-sulfonic acid)
410-960-692761-26-7Eye Dam. 1H318GHS05
Dgr
H318   
607-298-00-72-(trimethylammonium)ethox­ycarboxy­benzene-4-sulfonate411-010-3Skin Sens. 1H317GHS07
Wng
H317   
607-299-00-2methyl 3-(acetylthio)-2-methyl-pro­panoate411-040-797101-46-7Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
607-300-00-6trisodium [2-(5-chloro-2,6-difluoro­pyrimidin-4-ylamino)-5-(b-sulfa­moyl-c, d-sulfonato­phthalo­cyanin-a-yl-K4,N29,N30,N31,N32-sulfo­nyl­ami­no)ben­zoato(5-)]cuprate(II)
where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25
411-430-7Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-301-00-1reaction mass of: dodecanoic acid;
poly(1-7)lactate esters of dodecanoic acid
411-860-5Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-302-00-7reaction mass of: tetradecanoic acid;
poly(1-7)lactate esters of tetradecanoic acid
411-910-6Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H315
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H411
   
607-303-00-21-cyclopropyl-6,7-difluo­ro-1,4-dihydro-4-oxoquino­line-3-carboxylic acid413-760-793107-30-3Repr. 2
Aquatic Chronic 3
H361f
(*)(*)(*)
H412
GHS08
Wng
H361f
(*)(*)(*)
H412
   
607-304-00-8fluazifop-butyl (ISO);
butyl (RS)-2-[4-(5-trifluoro­methyl-2-pyri­dyloxy)phe­noxy]propionate
274-125-669806-50-4Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D
(*)(*)(*)
H400
H410
GHS08
GHS09
Dgr
H360D
(*)(*)(*)
H410
   
607-305-00-3fluazifop-P-butyl (ISO);
butyl (R)-2-[4-(5-trifluo­romethyl-2-pyri­dyloxy)pheno­xy]propio­nate
79241-46-6Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d
(*)(*)(*)
H400
H410
GHS08
GHS09
Wng
H361d
(*)(*)(*)
H410
   
607-306-00-9chlozolinate (ISO);
ethyl (RS)-3-(3,5-dichloro­phenyl)-5-methyl-2,4-dioxo-oxa­zolidine-5-carboxylate
282-714-484332-86-5Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Wng
H351
H411
   
607-307-00-4vinclozolin (ISO);
N-3,5-dichlorophenyl-5-me­thyl-5-vinyl-1,3-oxazoli­dine-2,4-dione
256-599-650471-44-8Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Chronic 2
H351
H360FD
H317
H411
GHS08
GHS07
GHS09
Dgr
H351
H360FD
H317
H411
   
607-308-00-Xesters of 2,4-DAcute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
  A
607-309-00-5carfentrazone-ethyl (ISO);
ethyl (RS)-2-chloro-3-[2-chlo­ro-4-fluoro-5-[4-difluoro­methyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phe­nyl]propio­nate
128639-02-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-310-00-0kresoxim-methyl (ISO);
methyl (E)-2-methoxyi­mino-[2-(o-tolyloxy­methyl)phe­nyl]acetate
143390-89-0Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
   
607-311-00-6benazolin-ethyl;
ethyl 4-chloro-2-oxo-2H-benzo­thiazole-3-acetate
246-591-025059-80-7Aquatic Chronic 2H411GHS09H411   
607-312-00-1methoxyacetic acid210-894-6625-45-6Repr. 1B
Acute Tox. 4 (*)
Skin Corr. 1B
H360FD
H302
H314
GHS08
GHS05
GHS07
Dgr
H360FD
H302
H314
 STOT SE 3;
H335: C ≥ 5 %
 
607-313-00-7neodecanoyl chloride254-875-040292-82-8Acute Tox. 2 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H330
H302
H314
GHS06
GHS06
Dgr
H330
H302
H314
 STOT SE 3;
H335: C ≥ 5 %
 
607-314-00-2ethofumesate (ISO);
(±)-2-ethoxy-2,3-dihydro-3,3-dimethylben-
zofuran-5-yl methanesulfonate
247-525-326225-79-6Aquatic Chronic 2H411GHS09H411   
607-315-00-8glyphosate (ISO);
N-(phosphonomethyl)glycine
213-997-41071-83-6Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411